consenting patients with clinical and electrocardiographic signs of acute myocardial infarction were studied angiographically and 240 qualifying patients with documented coronary occlusion ( flow grade 0 or 1 ) were randomized to treatment in less than 6 h of symptom onset ( mean 3.4 h , range 0.4 to 6.0 ) with either intravenous apsac ( 30 u in 2 to 4 min ) or intracoronary streptokinase ( 160,000 u over 60 min ) .
C0078956
apsac
C0038418
streptokinase